非共面连续容积旋转调强放疗中机械误差监测及其剂量学影响
结果显示MLC位置、机架角、O环角和MU的RMSE分别小于0.1 mm、0.2°、0.1°和0.4 MU,全程剂量误差较小,颅底肿瘤最大累积剂量误差为1.6%。
要点
- VMDWAT全程机械误差小且稳定,MLC位置RMSE<0.1 mm,机架角RMSE<0.2°。
- 颅底肿瘤绝对平均剂量误差<1.4%,前列腺癌<0.3%。
- 最大累积剂量误差为1.6%(颅底肿瘤患者),所有剂量体积参数相对计划偏差有限。
核心结论
- VMDWAT在整个治疗过程中MLC位置、机架旋转、O环旋转和MU高度精确且稳定,每日机械误差导致的剂量学误差较小,整体提供高投照精度和稳定性。
主要发现
- MLC位置、机架角、O环角和MU的RMSE分别小于0.1 mm、0.2°、0.1°和0.4 MU。
- 颅底肿瘤全程绝对平均剂量误差和两倍标准差分别小于1.4%和1.1%;前列腺癌分别小于0.3%和0.5%。
- 颅底肿瘤患者中观察到最大剂量误差为2.5%,该患者累积每日投照剂量分布中所有剂量体积参数相对计划的最大误差达1.6%。
临床怎么用
- 可利用日志文件在VMDWAT治疗全程监测机械误差并重建剂量,验证投照精度。
- 对于颅底肿瘤等复杂部位,需关注较大单次剂量误差及累积剂量偏差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Volumetric-modulated Dynamic WaveArc therapy (VMDWAT) is a non-coplanar continuous volumetric modulated radiation therapy (VMAT) delivery technique. Here, we monitored mechanical errors and their impact on dose distributions in VMDWAT using logfiles throughout the course of treatment. METHODS: Fifteen patients were enrolled (2 skull base tumor patients and 13 prostate cancer patients). VMDWAT plans were created for the enrolled patients. The prescribed dose for the skull base tumor was set as 54 Gy at 1.8 Gy per fraction, and that for the prostate cancer was set as 72 to 78 Gy at 2 Gy per fraction. We acquired logfiles to monitor mechanical errors and their impact on dose distribution in each fraction. The root mean square error (RMSE) in the multi-leaf collimator (MLC), gantry angle, O-ring angle and monitor unit (MU) were calculated using logfiles throughout the course of VMDWAT for each patient. The dosimetric impact of mechanical errors throughout the course of VMDWAT was verified using a logfile-based dose reconstruction method. Dosimetric errors between the reconstructed plans and the original plans were assessed. RESULTS: A total of 517 datasets, including 55 datasets for the 2 skull base tumor patients and 462 datasets for the 13 prostate cancer patients, were acquired. The RMSE values were less than 0.1 mm, 0.2°, 0.1°, and 0.4 MU for MLC position, gantry angle, O-ring angle, and MU, respectively. For the skull base tumors, the absolute mean dosimetric errors and two standard deviations throughout the course of treatment were less than 1.4% and 1.1%, respectively. For prostate cancer, these absolute values were less than 0.3% and 0.5%, respectively. The largest dosimetric error of 2.5% was observed in a skull base tumor patient. The resultant dosimetric error in the accumulated daily delivered dose distribution, in the patient with the largest error, was up to 1.6% for all dose-volumetric parameters relative to the planned dose distribution. CONCLUSIONS: MLC position, gantry rotation, O-ring rotation and MU were highly accurate and stable throughout the course of treatment. The daily dosimetric errors due to mechanical errors were small. VMDWAT provided high delivery accuracy and stability throughout the course of treatment. TRIAL REGISTRATION: UMIN000023870 . Registered: 1 October 2016.
引用
- Hirashima H, Nakamura M, Miyabe Y, et al. Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy. Radiat Oncol. 2018. PMID: 29444693. doi:10.1186/s13014-018-0972-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。